Scientists Predict “Brain Drain” From States That Ban Abortion
Following the overturning of Roe v. Wade, numerous researchers have announced plans to either vacate or decline career opportunities in states where abortion is or will soon be illegal.
Scientists Predict “Brain Drain” From States That Ban Abortion
Scientists Predict “Brain Drain” From States That Ban Abortion
Following the overturning of Roe v. Wade, numerous researchers have announced plans to either vacate or decline career opportunities in states where abortion is or will soon be illegal.
Following the overturning of Roe v. Wade, numerous researchers have announced plans to either vacate or decline career opportunities in states where abortion is or will soon be illegal.
David Schwartz of the Illinois Institute of Technology-Chicago, Kent College of Law, discusses the impact of the US Supreme Court unanimously striking down Myriad Genetics' patent of human BRCA genes and tests to detect mutations in them.
Last week’s Supreme Court decision to invalidate patents on human genes was a win for patients, independent researchers, and even the wider biotech industry.
The Justices have decided that isolated sequences of human DNA are not eligible for patent protection, but rules that artificial sequences can be patented.
A decision will not be reached until later in the year, but the United States’ top justices appear to be inclined to rule against the validity of patenting human genes.
The highest court in the country has declined to hear an appeal regarding the federal funding of human embryonic stem cell research, allowing such spending to continue.